michigan semaglutide vomiting class action digestive blockage gastrointestinal obstruction Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) Lawsuit filed against Ozempic GLP-1 Lawsuit & Gastroparesis

Dose AI tracks protein, fiber, calories, and water against daily goals suited to GLP-1 appetites

Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder

doi: 10.1016/j.jemrpt.2025.100139 14 SoodNBansalOGargRHoskoteA

Interplay between m6A RNA methylation and ferroptosis in diabetes development and therapy N6-methyladenosine (m6A), a common RNA modulator, can affect critical genes related to ferroptosis, including cyclin-dependent kinase inhibitor 1A (CDKN1A), myo-inositol oxygenase (MIOX), proto-oncogene, BHLH transcription factor (MYCN), and cluster of differentiation 82 (CD82)

Together, UTHealths press materials and the published ATTAIN2 trial offer regulators and frontline clinicians the data they will lean on as approval decisions move forward

Although most guidelines continue to recommend metformin as first-line anti-hyperglycemic therapy, the European Society of Cardiology [52] recommends that GLP-1RA or SGLT2i should be first-line therapy in individuals with ASCVD or at high or very high CV risk